Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 495174

Intraluminal brachytherapy in the management of squamous carcinoma of the esophagus


Frobe, Ana; Jones, Glenn; Jakšić, Blanka; Bokulić, Tomislav; Budanec, Mirjana; Mrčela, Iva; Staničić-Rokotov, Dinko; Hrabar, Davor; Bolanča, Ante; Rosenblatt, Eduardo; Kusić, Zvonko
Intraluminal brachytherapy in the management of squamous carcinoma of the esophagus // Diseases of the esophagus, 22 (2009), 6; 513-518 doi:10.1111/j.1442-2050.2009.00958.x (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 495174 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Intraluminal brachytherapy in the management of squamous carcinoma of the esophagus

Autori
Frobe, Ana ; Jones, Glenn ; Jakšić, Blanka ; Bokulić, Tomislav ; Budanec, Mirjana ; Mrčela, Iva ; Staničić-Rokotov, Dinko ; Hrabar, Davor ; Bolanča, Ante ; Rosenblatt, Eduardo ; Kusić, Zvonko

Izvornik
Diseases of the esophagus (1120-8694) 22 (2009), 6; 513-518

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
brachytherapy high dose rate; dysphagia; esophageal cancer; palliative care; quality of life

Sažetak
Intraluminal high dose rate brachytherapy (ILHDR BT) is one of several effective modalities for palliation of advanced esophageal cancer. Thirty patients with endoscopic-proven, mostly locally advanced, squamous cell carcinoma of the esophagus, not involving the gastroesophageal junction and without distant metastases, were included in this analysis. Twenty-nine patients received two ILHDR BT sessions of 8 Gy within a week and one patient received only one session. All patients were followed monthly. Outcomes included quality of life (QOL), symptoms control: dysphagia, regurgitation, odynophagia, and chest or back pain, as well as, overall survival. Through 4 months of follow-up, QOL was statistically improved (having lowered scores) in regards to feelings (P= 0.013), sleeping (P= 0.032), eating (P= 0.020), and social life (P= 0.002). The most significantly improved symptom was dysphagia (P < 0.006), with a reduction of 0.52 units or one-half grade. Regurgitation, odynophagia, and pain were lower during follow-up but were not statistically significant. The median overall survival from death of any cause was 165 days (with a 95% confidence interval of 128–195 days). In conclusion, ILHDR BT of advanced squamous esophageal cancer consisting of two out-patient procedures is very successful in achieving the primary objectives of the patients to reduce dysphagia and improve QOL.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
134-1342428-2430 - Karcinogeneza u štitnjači i gušavost u Hrvatskoj (Kusić, Zvonko, MZOS ) ( POIROT)

Ustanove:
KBC "Sestre Milosrdnice"

Profili:

Avatar Url Tomislav Bokulić (autor)

Avatar Url Ante Bolanča (autor)

Avatar Url Iva Mrčela (autor)

Avatar Url Davor Hrabar (autor)

Avatar Url Ana Fröbe (autor)

Avatar Url Mirjana Budanec (autor)

Avatar Url Zvonko Kusić (autor)

Citiraj ovu publikaciju

Frobe, Ana; Jones, Glenn; Jakšić, Blanka; Bokulić, Tomislav; Budanec, Mirjana; Mrčela, Iva; Staničić-Rokotov, Dinko; Hrabar, Davor; Bolanča, Ante; Rosenblatt, Eduardo; Kusić, Zvonko
Intraluminal brachytherapy in the management of squamous carcinoma of the esophagus // Diseases of the esophagus, 22 (2009), 6; 513-518 doi:10.1111/j.1442-2050.2009.00958.x (međunarodna recenzija, članak, znanstveni)
Frobe, A., Jones, G., Jakšić, B., Bokulić, T., Budanec, M., Mrčela, I., Staničić-Rokotov, D., Hrabar, D., Bolanča, A., Rosenblatt, E. & Kusić, Z. (2009) Intraluminal brachytherapy in the management of squamous carcinoma of the esophagus. Diseases of the esophagus, 22 (6), 513-518 doi:10.1111/j.1442-2050.2009.00958.x.
@article{article, year = {2009}, pages = {513-518}, DOI = {10.1111/j.1442-2050.2009.00958.x}, keywords = {brachytherapy high dose rate, dysphagia, esophageal cancer, palliative care, quality of life}, journal = {Diseases of the esophagus}, doi = {10.1111/j.1442-2050.2009.00958.x}, volume = {22}, number = {6}, issn = {1120-8694}, title = {Intraluminal brachytherapy in the management of squamous carcinoma of the esophagus}, keyword = {brachytherapy high dose rate, dysphagia, esophageal cancer, palliative care, quality of life} }
@article{article, year = {2009}, pages = {513-518}, DOI = {10.1111/j.1442-2050.2009.00958.x}, keywords = {brachytherapy high dose rate, dysphagia, esophageal cancer, palliative care, quality of life}, journal = {Diseases of the esophagus}, doi = {10.1111/j.1442-2050.2009.00958.x}, volume = {22}, number = {6}, issn = {1120-8694}, title = {Intraluminal brachytherapy in the management of squamous carcinoma of the esophagus}, keyword = {brachytherapy high dose rate, dysphagia, esophageal cancer, palliative care, quality of life} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Uključenost u ostale bibliografske baze podataka:


  • Academic Search Complete


Citati





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font